GlassScriptPhysician profile
Michael T Caton
NPI 1609289875
$3,216.70
in general payments reported to CMS, 2019-2025
14 companies · $731 in 2025
The $731 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.94 · 2021: $550 · 2022: $675 · 2023: $952 · 2024: $289 · 2025: $731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,972.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,439.15 | 2021-2025 | Target, Spinejack, Surpass Evolve |
| Depuy Synthes Sales INC. | $475.51 | 2022-2024 | Emboguard, Embotrap, Cerepak Uniform |
| Imperative Care, INC | $392.96 | 2024-2025 | Zoom 88-T Large Distal Platform, Zoom 4s Catheter, Zoom Reperfusion Catheter |
| Route 92 Medical, INC. | $380.78 | 2023-2025 | 8f Base Camp Sheath System |
| Microvention, INC. | $204.38 | 2021-2025 | Web Aneurysm Embolization System, Sofia 6f-131cm Str, Stent |
| Penumbra, INC. | $122.60 | 2020-2025 | Red 72 |
| Neurelis, INC. | $70.77 | 2024-2025 | Valtoco |
| Medtronic, INC. | $31.62 | 2025 | Percept PC Brainsense |
| Terumo Medical Corporation | $19.61 | 2025 | R2p Misago |
| Alexion Pharmaceuticals, INC. | $19.49 | 2025 | Ultomiris |
| Chiesi USA, INC. | $17.67 | 2022 | |
| Nevro Corp. | $17.31 | 2022 | |
| Ucb, INC. | $16.15 | 2024 | Briviact |
| Lenoss Medical INC | $8.70 | 2025 | Osteopearl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Caton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.